Author: Arvin Arvin
finnCap Research Company Notes – 30 January 2020
Categories: NewsfinnCap Research Company Notes – 30 January 2020 Best of the Best (BOTB) : Corp H1FY20 = another positive surprise. Raising forecasts again. Key data BOTB has delivered better-than-expected H1FY20 results. To reflect the strong H1 performance and the “encouraging” momentum into H2, we raise both our FY20 and FY21 PBT forecasts by +18% and
finnCap Tech Chat | Making the most of our masochism
Categories: BlogfinnCap Tech Chat | Making the most of our masochism It’s difficult not to feel sorry for my kids’ old toys when the shiny new toys come along and command all their attention. The older toys appear forlorn and unloved, if that’s even possible. Such anthropomorphism (attributing human characteristics to objects) isn’t uncommon, and has
Rude Health | finnCap Life Sciences quarterly sector note January 2020
Categories: NewsRude Health | finnCap Life Sciences quarterly sector note January 2020 Rude Health | finnCap Life Sciences quarterly sector note Summary from finnCap Life Sciences: The AIM Healthcare index rose by 13% in 2019, marginally outperforming the AIM All Share (+12%). AIM Healthcare was outperformed by the larger cap FT All Share Health and World
finnCap Research Company Notes – 28 January 2020
Categories: NewsfinnCap Research Company Notes – 28 January 2020 Avacta (AVCT) : Corp TMAC – proof of concept for novel Affimer conjugate Key data The news that Avacta’s first TMAC™ resulted in a significant reduction in tumour growth in animal studies compared with Merck/Pfizer’s Bavencio (avelumab) is a further significant step in the development of its
2020: A renaissance year for IPOs
Categories: Blog2020: A renaissance year for IPOs The IPO market awakens Marking the release of our new guide to IPO for entrepreneurs and business leaders, Stuart Andrews, Managing Director at finnCap explains why the public markets offer fresh opportunities for the right companies in 2020. “2019 was a year of political turmoil in the UK. There was
finnCap Research Company Notes – 23 January 2020
Categories: NewsfinnCap Research Company Notes – 23 January 2020 Avingtrans (AVG) : Corp Upbeat trading update Key data In a brief trading update, the company confirms it is trading in line with market expectations, having continued to perform well in the first half. The order book and pipeline prospects remain robust, and good progress has been
finnCap Research Company Notes – 22 January 2020
Categories: NewsfinnCap Research Company Notes – 22 January 2020 ANGLE (AGL) : Corp De Novo submission to FDA expected by end Q1 2020 Key data ANGLE confirmed that following a formal face-to-face meeting with the FDA last week it expects to file a De Novo submission with the FDA for Parsortix by the end of Q1
finnCap Research Company Notes – 21 January 2020
Categories: NewsfinnCap Research Company Notes – 21 January 2020 dotDigital (DOTD) : Corp Interim trading update Key data dotDigital’s trading update confirms strong performance for the six months to December 2019, with adj. EBITDA and adj. PBT expected in line with expectations. Organic revenue grew 15% to £23.1m, primarily driven by direct sales to new and
finnCap Research Company Notes – 20 January 2020
Categories: NewsfinnCap Research Company Notes – 20 January 2020 By jonathan wright Europa Oil & Gas (EOG) : Corp Wressled! Key data After a highly protracted process, Europa’s Wressle oil field development has finally been granted planning consent. This paves the way for the field to be brought into production this year, delivering much needed cash
finnCap Sales Perspectives 2020
Categories: NewsfinnCap Sales Perspectives 2020 A new year, a new decade, and a brand-new set of exciting stock ideas from the sales team here at finnCap. This exclusive and eagerly awaited document presents our highest conviction non corporate stock recommendations for the coming year. These stocks look incredibly well placed to produce substantial outperformance, so we
